USPTO trademark

PRICESYNC

Under examinationUSPTOWord markClass 35Class 36Class 44

"PRICESYNC" is a word mark owned by Prime Therapeutics LLC, filed at the USPTO on May 1, 2025. It is under examination and covers classes 35, 36 and 44.

Official USPTO record
PRICESYNC trademark as filed
As filed with the USPTO
Status
Under examination
Since September 4, 2026
Filed
May 1, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99166742
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns PRICESYNC

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services PRICESYNC is filed for, grouped by Nice class.

  • Pharmaceutical cost management services; medical cost management in the field of pharmaceuticals; business data analyzing and reporting services in the fields of healthcare and pharmaceuticals; business services provided to the healthcare industry, namely, the collection and reporting of data pertaining to pharmaceuticals for business purpose

  • Pharmacy benefit management services; financial consulting relating to healthcare, namely, developing pricing models to determine reimbursement rates for drugs

  • Pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consulting services; health care services, namely, disease management programs; medication therapy management in the nature of medication review being medication counseling and medical and pharmaceutical consulting services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas/email correspondence entered
  2. Correspondence received in law office
  3. Teas response to office action received
  4. Application extension granted/receipt provided
  5. Application extension to response period - received
  6. Notification of non-final action e-mailed
  7. Non-final action e-mailed
  8. Non-final action written
  9. Assigned to examiner
  10. New application office supplied data entered

2 earlier steps on the official record.

FAQ

About PRICESYNC

Who owns the trademark "PRICESYNC"?

The USPTO trademark "PRICESYNC" (application 99166742) is owned by Prime Therapeutics LLC.

What is the status of "PRICESYNC"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PRICESYNC and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2abd-8097-7344-a451-86e47b6d090b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2abd-8097-7344-a451-86e47b6d090b",
  "object": "trademark",
  "mark_text": "PRICESYNC",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99166742",
  "filing_date": "2025-05-01",
  "nice_classes": [
    35,
    36,
    44
  ],
  "owners": [
    {
      "name": "Prime Therapeutics LLC",
      "entity_id": "ent_019eb6fe-75bc-7498-b91a-6bffe9e5b38d"
    }
  ]
}